The finding that PFKFB3 expression is significantly increased in both colon and rectal carcinoma confirms our hypothesis that a metabolic shift towards glycolysis happens during colon- and rectal-carcinogenesis, and that indeed its increased expression affects patients’ outcomes. The gene discussed is PFKFB3; the disease is rectal carcinoma.